尖峰集团(600668.SH)获得磷酸特地唑胺化学原料药上市申请批准

Core Viewpoint - The announcement indicates that Jianfeng Group's subsidiary, Anhui Jianfeng Beika Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the marketing application of the chemical raw material drug, Phosphoric Acid Tedizolid [1] Group 1 - Jianfeng Beika has established the necessary production line for Phosphoric Acid Tedizolid, which signifies its readiness to manufacture the drug [1] - The approval confirms that the raw material drug meets the national technical standards for raw material drug review, allowing it to be sold in the domestic market [1] - This development is expected to help expand the business scope of the subsidiary [1]